76° Good Evening
76° Good Evening

Nation briefs


Dems defend Menendez

New Jersey has been here before. A senior U.S. senator's career hangs in the balance as he faces sharp questions about lavish gifts from a campaign donor. But the reactions to the scandal around former Sen. Robert Torricelli, who was forced to give up his re-election bid in 2002, and Sen. Robert Menendez, indicted on corruption charges last week, have been starkly different. Fellow Democrats applied the pressure that pushed Torricelli over the political precipice, ending his career. In Menendez's case, support has flowed from all corners of the Democratic establishment. The bottom fell out on Torricelli as he skidded toward Election Day, with Democrats facing the prospect of turning over a Senate seat to Republicans for a six-year term. Menendez won't be on the ballot again until 2018.


2 women, 3 children shotFive people, including three children, were wounded after being shot inside a townhome in Indianapolis last night, police said. Lt. Richard Riddle said three male suspects were inside the home with the victims when the shooting occurred. The victims were two women and three children, ages 6, 3 and 6 months, who were all related. All five were hospitalized in serious condition. Riddle said police believe the suspects knew the victims. It wasn't immediately clear what prompted the shooting. No arrests have been made. MASSACHUSETTS

Medical device tax a target

Rep. Seth Moulton is meeting today with members of the state's medical community to highlight a bill to roll back a tax aimed at medical device makers. The Democratic congressman is one of more than 270 co-sponsors of the bipartisan Protect Medical Innovation Act. Other members of the state's all-Democratic congressional delegation have co-sponsored the measure. The state's Democratic senators, Edward Markey and Elizabeth Warren, also support rescinding the tax, which was in President Barack Obama's 2010 health care law. Massachusetts is home to many medical device firms.


We're revamping our Comments section. Learn more and share your input.

More news